亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會(huì)員登錄|免費(fèi)注冊(cè)|忘記密碼|管理入口 返回主站||保存桌面|手機(jī)瀏覽|聯(lián)系方式|購(gòu)物車(chē)
企業(yè)會(huì)員第1年

濟(jì)南宏方德醫(yī)藥科技有限公司(銷(xiāo)售三部)  

沒(méi)有填寫(xiě)主營(yíng)業(yè)務(wù)~~

搜索
新聞中心
  • 暫無(wú)新聞
產(chǎn)品分類(lèi)
  • 暫無(wú)分類(lèi)
聯(lián)系方式
  • 聯(lián)系人:王紅
  • 電話(huà):0531-55505896
  • QQ:2659530578
站內(nèi)搜索
 
榮譽(yù)資質(zhì)
  • 暫未上傳
友情鏈接
  • 暫無(wú)鏈接
120011-70-3
單價(jià) 20.00 / 千克對(duì)比
銷(xiāo)量 暫無(wú)
發(fā)貨 山東濟(jì)南市付款后3天內(nèi)
庫(kù)存 9000千克起訂1千克
品牌 濟(jì)南宏方德
型號(hào) 120011-70-3
規(guī)格 千克
過(guò)期 長(zhǎng)期有效
更新 2014-04-08 09:19
 
詳細(xì)信息

  • 英文名稱(chēng):
  • Donepezil hydrochloride
  • 英文別名:
  • ;Donepezil HCl;Aricept, E-2020 Donepezil HCl;2-(1-Benzylpiperidin-4-ylmethyl)-5,6-dimethoxyindan-1-one hydrochloride;DonepezilHCL;2,3-dihydro-5,6-dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl]methyl]-1h-inden-1-one hydrochloride;AKOS 226-31;E-2020;ARICEPT;DonepezilHcl120011-70-3;2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one hydrochloride (1:1);2,3-dihydro-5,6-dimethoxy-2-{[1-(phemylmethyl)-4-piperidinyl]methyl}-1H-indan-1-one HCL;Donezepil hydrochloride;
  • 分子式:
  • C24H30ClNO3
  • 分子量:
  • 415.9529
  • InChI:
  • InChI=1/C24H29NO3.ClH/c1-27-22-14-19-13-20(24(26)21(19)15-23(22)28-2)12-17-8-10-25(11-9-17)16-18-6-4-3-5-7-18;/h3-7,14-15,17,20H,8-13,16H2,1-2H3;1H
  • 沸點(diǎn):
  • 527.9°C at 760 mmHg
  • 閃點(diǎn):
  • 273.1°C
  • 物化性質(zhì):
  • 白色結(jié)晶。
©2025 濟(jì)南宏方德醫(yī)藥科技有限公司(銷(xiāo)售三部) 版權(quán)所有   技術(shù)支持:化工網(wǎng)   訪問(wèn)量:7731  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |